Overview

Effect of Rosiglitazone

Status:
Completed

Trial end date:
2004-11-01

Target enrollment:

Participant gender:

Summary

To evaluate : - acute effects of a single dose of 8 mg rosiglitazone (therapeutic dose) - on insulin secretion and - insulin sensitivity in 12 healthy male subjects.

Phase:

N/A

Details

Lead Sponsor:

University Hospital, Montpellier

Treatments:

Rosiglitazone